Does PALBOCICLIB Cause Metastases to bone? 793 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 793 reports of Metastases to bone have been filed in association with PALBOCICLIB (Ibrance). This represents 0.9% of all adverse event reports for PALBOCICLIB.
793
Reports of Metastases to bone with PALBOCICLIB
0.9%
of all PALBOCICLIB reports
30
Deaths
88
Hospitalizations
How Dangerous Is Metastases to bone From PALBOCICLIB?
Of the 793 reports, 30 (3.8%) resulted in death, 88 (11.1%) required hospitalization, and 33 (4.2%) were considered life-threatening.
Is Metastases to bone Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for PALBOCICLIB. However, 793 reports have been filed with the FAERS database.
What Other Side Effects Does PALBOCICLIB Cause?
Fatigue (15,190)
White blood cell count decreased (11,273)
Neoplasm progression (10,885)
Death (8,410)
Nausea (8,189)
Neutropenia (6,423)
Alopecia (6,201)
Diarrhoea (5,635)
Asthenia (3,660)
Off label use (3,405)
What Other Drugs Cause Metastases to bone?
LETROZOLE (1,735)
RIBOCICLIB (1,538)
FULVESTRANT (1,525)
ZOLEDRONIC ACID (1,087)
DENOSUMAB (1,053)
TAMOXIFEN (894)
LEUPROLIDE (848)
EVEROLIMUS (845)
PACLITAXEL (820)
CAPECITABINE (763)
Which PALBOCICLIB Alternatives Have Lower Metastases to bone Risk?
PALBOCICLIB vs PALIPERIDONE
PALBOCICLIB vs PALIVIZUMAB
PALBOCICLIB vs PALONOSETRON
PALBOCICLIB vs PAMIDRONATE
PALBOCICLIB vs PAMIDRONIC ACID